MARLYNNE LIEVORE: Open Payments
NPI 1699472159 · WINCHESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,912 in 124 payments from 16 companies in 2025. Trend: 2023 $2,348 · 2024 $2,730 · 2025 $2,912
Food & beverage: $2,912
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $462 |
| GENZYME CORPORATION | 13 | $397 |
| Organon LLC | 9 | $261 |
| Incyte Corporation | 10 | $256 |
| ABBVIE INC. | 22 | $246 |
| PFIZER INC. | 1 | $200 |
| Novartis Pharmaceuticals Corporation | 9 | $194 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $178 |
| Galderma Laboratories, L.P. | 14 | $173 |
| E.R. Squibb & Sons, L.L.C. | 11 | $140 |
Products named: TREMFYA, DUPIXENT, OPZELURA, CIBINQO, SKYRIZI, NEMLUVIO, Sotyktu, Bimzelx.
Industry payments across MA — which companies pay providers there.
